AI RESEARCH
TuLaBM: Tumor-Biased Latent Bridge Matching for Contrast-Enhanced MRI Synthesis
arXiv CS.LG
•
ArXi:2603.19386v1 Announce Type: cross Contrast-enhanced magnetic resonance imaging (CE-MRI) plays a crucial role in brain tumor assessment; however, its acquisition requires gadolinium-based contrast agents (GBCAs), which increase costs and raise safety concerns. Consequently, synthesizing CE-MRI from non-contrast MRI (NC-MRI) has emerged as a promising alternative.